Heart failure with preserved ejection fraction: insights from recent clinical researches

Citations

WEB OF SCIENCE

15
Citations

SCOPUS

14

초록

Heart failure (HF) with preserved ejection fraction (HFpEF) accounts for nearly half of the cases of HF and its incidence might be increasing with the aging society. Patients with HFpEF present with significant symptoms, including exercise intolerance, impaired quality of life, and have a poor prognosis as well as frequent hospitalization and increased mortality compared with HF with reduced ejection fraction. The concept of HFpEF is still evolving and may be a virtual complex rather than a real systemic disorder. Thus, beyond solely targeting cardiac abnormalities management strategies need to be extended, such as left ventricular diastolic dysfunction. In this review, we examine new diagnostic algorithms, pathophysiology, current management status, and ongoing trials based on heterogeneous pathophysiology and etiology in HFpEF.

키워드

Heart failurePreserved ejection fractionTherapyANGIOTENSIN-ALDOSTERONE SYSTEMPATIENTS GREATER-THAN-OR-EQUAL-TO-65 YEARSCORONARY MICROVASCULAR DYSFUNCTIONREDUCE LAP-HFSYSTOLIC FUNCTIONOLDER PATIENTSBETA-BLOCKERSBLOOD-PRESSUREVENTRICULAR-FUNCTIONEXERCISE CAPACITY
제목
Heart failure with preserved ejection fraction: insights from recent clinical researches
저자
Kim, Mi-NaPark, Seong-Mi
DOI
10.3904/kjim.2020.104
발행일
2020-05
유형
Review
저널명
The Korean Journal of Internal Medicine
35
3
페이지
514 ~ 534